Strehblow, Christoph <br/><br/>
Comparison of different biologic agents in patients with rheumatoid arthritis after failure of the first biologic therapy.  [electronic resource] 

 -  Wiener medizinische Wochenschrift (1946)  May 2010 
 - 225-9 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1563-258X 
<br/><br/><label>Standard No.: </label>10.1007/s10354-010-0796-z  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab<br/>Antibodies, Monoclonal--adverse effects<br/>Antibodies, Monoclonal, Humanized<br/>Antirheumatic Agents--adverse effects<br/>Arthritis, Rheumatoid--drug therapy<br/>Biological Products--adverse effects<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Drug Substitution<br/>Drug Therapy, Combination<br/>Drug Tolerance<br/>Etanercept<br/>Humans<br/>Immunoglobulin G--adverse effects<br/>Infliximab<br/>Infusions, Intravenous<br/>Injections, Subcutaneous<br/>Interleukin 1 Receptor Antagonist Protein--adverse effects<br/>Longitudinal Studies<br/>Receptors, Tumor Necrosis Factor--antagonists & inhibitors<br/>Treatment Failure<br/>Treatment Outcome